Hazel Marimbizain BULAWAYO THE introduction of Lenacapavir, a long-acting injection, has triggered an unprecedented surge in HIV prevention uptake among Zimbabwean men.Zimbabwe rolled out Lenacapavir in February, positioning itself among the first countries in Africa to introduce the innovative prevention method.The programme aims to reach about 46 000 people considered vulnerable to HIV infection.Speaking at…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions